skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Mixed beam radiotherapy and combination chemotherapy in localized pancreatic adenocarcinoma - preliminary results

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

A pilot study of mixed beam radiotherapy (fast neutrons alternating with photons) followed by combination chemotherapy with SMF (streptozotocin, 5-flouoruracil, mitomycin C) in localized pancreatic cancer was performed. Thirteen patients were treated and a median survival of 10.0 months was noted (range 5-30+). Toxicity was mild to moderate. Further studies of radiation and chemotherapy are indicated.

Research Organization:
Cleveland Clinic Foundation, OH
OSTI ID:
7069305
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 8:7
Country of Publication:
United States
Language:
English

Similar Records

Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
Journal Article · Sat Nov 01 00:00:00 EDT 2008 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:7069305

3D Radiotherapy Can Be Safely Combined With Sandwich Systemic Gemcitabine Chemotherapy in the Management of Pancreatic Cancer: Factors Influencing Outcome
Journal Article · Tue Apr 01 00:00:00 EDT 2008 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:7069305

Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer
Journal Article · Fri Dec 01 00:00:00 EST 2006 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:7069305